Colon polyps medical therapy

Jump to navigation Jump to search

Colon polyps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Colon polyps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Colon polyps medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Colon polyps medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Colon polyps medical therapy

CDC on Colon polyps medical therapy

Colon polyps medical therapy in the news

Blogs on Colon polyps medical therapy

Directions to Hospitals Treating Colon polyps

Risk calculators and risk factors for Colon polyps medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

The mainstay of treatment for colon polyps is surgery. Aspirin is recommended to prevent recurrent polyps or conversion of colon polyps to colorectal cancer.

Medical Therapy

References

  1. Whitlock EP, Williams SB, Burda BU, et al. Aspirin Use in Adults: Cancer, All-Cause Mortality, and Harms: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. (Evidence Syntheses, No. 132.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK321643/
  2. <ref>Whitlock EP, Burda BU, Williams SB, Guirguis-Blake JM, Evans CV (2016). "Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force". Ann. Intern. Med. 164 (12): 826–35. doi:10.7326/M15-2112. PMID 27064261.
  3. Chubak J, Kamineni A, Buist DSM, et al. Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Sep. (Evidence Syntheses, No. 133.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK321661/
  4. Dehmer SP, Maciosek MV, Flottemesch TJ, LaFrance AB, Whitlock EP (2016). "Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force". Ann. Intern. Med. 164 (12): 777–86. doi:10.7326/M15-2129. PMID 27064573.

​​​​